- Home
- WKSP vs TOVX Comparison
WKSP vs TOVX Comparison
Compare WKSP & TOVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | WKSP | TOVX |
|---|---|---|
| Founded | 2003 | 2001 |
| Country | United States | United States |
| Employees | 81 | N/A |
| Industry | Auto Parts:O.E.M. | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.2M | 14.7M |
| IPO Year | N/A | 2012 |
Fundamental Metrics
Financial Performance| Metric | WKSP | TOVX |
|---|---|---|
| Price | $0.87 | $0.25 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | ★ $9.25 | $1.00 |
| AVG Volume (30 Days) | 8.2M | ★ 11.8M |
| Earning Date | 05-15-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 89.07 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $131.96 | N/A |
| Revenue Next Year | $24.81 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.57 | $0.16 |
| 52 Week High | $4.90 | $0.86 |
Technical Indicators
Market Signals| Indicator | WKSP | TOVX |
|---|---|---|
| Relative Strength Index (RSI) | 57.06 | 40.67 |
| Support Level | $0.66 | $0.18 |
| Resistance Level | $1.03 | $0.28 |
| Average True Range (ATR) | 0.12 | 0.03 |
| MACD | 0.03 | -0.00 |
| Stochastic Oscillator | 56.50 | 11.51 |
Price Performance
Historical ComparisonAbout WKSP Worksport Ltd.
Worksport Ltd through its subsidiaries, designs, develops, manufactures, and owns the IP on a variety of tonneau covers, solar integrations, and NP (Non-Parasitic), Hydrogen-based true green energy solutions for the sustainable, clean energy, and automotive industries. The company's product includes soft vinyl tonneau covers and hard aluminum tonneau covers. It operates in two reporting segments for financial reporting purposes: Hard Tonneau Covers and Soft Tonneau Covers. Geographically, the company operates in Canada, United States and Other Countries.
About TOVX Theriva Biologics Inc.
Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system. Product Candidates includes SYN-004 (ribaxamase) and SYN-020.